Evaluation of P-glycoprotein (Pgp) expression in human osteosarcoma by high-throughput tissue microarray.

J Orthop Res 2016 09 2;34(9):1606-12. Epub 2016 Feb 2.

Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 02114.

Survival of osteosarcoma patients is currently limited by the development of metastases and multidrug resistance (MDR). A well-established cause of MDR involves overexpression of P-glycoprotein (Pgp) in tumor cells. However, some discrepancies still exist as to the clinical significance of Pgp in osteosarcoma. We sought to elucidate further whether the Pgp expression correlated with clinical behavior in a series of patients with osteosarcoma via high-throughput tissue microarray (TMA) analysis. Immunohistochemical analysis of Pgp expression in a TMA of 114 specimens with a retrospective review of 70 osteosarcoma patients admitted to the Massachusetts General Hospital (MGH) was performed. High Pgp expression was correlated with metastasis development and poor response to pre-operative chemotherapy in osteosarcoma patients. Eighteen of the fifty-seven patients initially admitted with primary osteosarcoma showed high Pgp expression. Among these 18 patients with high Pgp expression, 13 of 18 (72%) patients eventually developed metastases. There was no significant clinical relevance between Pgp expression and osteosarcoma survival. These results support that high expression of Pgp is important, but cannot be assigned as, an individual predictor in the development of human osteosarcoma. © 2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:1606-1612, 2016.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jor.23173DOI Listing
September 2016
20 Reads

Publication Analysis

Top Keywords

pgp expression
28
high pgp
12
osteosarcoma patients
12
pgp
10
osteosarcoma
9
osteosarcoma high-throughput
8
tissue microarray
8
expression correlated
8
human osteosarcoma
8
high-throughput tissue
8
expression
8
p-glycoprotein pgp
8
patients
7
response pre-operative
4
primary osteosarcoma
4
poor response
4
correlated metastasis
4
metastasis development
4
development poor
4
pre-operative chemotherapy
4

References

(Supplied by CrossRef)
The epidemiology of osteosarcoma
Ottaviani et al.
Cancer Treat Res 2009
Emerging drugs for high-grade osteosarcoma
Hattinger et al.
Expert Opin Emerg Drugs 2010
Osteosarcoma: a review of diagnosis, management, and treatment strategies
Geller et al.
Clin Adv Hematol Oncol 2010
Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
Meyers et al.
Expert Rev Anticancer Ther 2009
Mechanisms of multidrug resistance in cancer
Gillet et al.
Methods Mol Biol 2010

Similar Publications